Published in Cell Res on April 01, 2009
A novel C53/LZAP-interacting protein regulates stability of C53/LZAP and DDRGK domain-containing Protein 1 (DDRGK1) and modulates NF-kappaB signaling. J Biol Chem (2010) 1.23
A novel LZAP-binding protein, NLBP, inhibits cell invasion. J Biol Chem (2010) 1.17
Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma. PLoS One (2011) 0.89
LZAP inhibits p38 MAPK (p38) phosphorylation and activity by facilitating p38 association with the wild-type p53 induced phosphatase 1 (WIP1). PLoS One (2011) 0.86
Tumor suppressor Lzap regulates cell cycle progression, doming, and zebrafish epiboly. Dev Dyn (2011) 0.84
Neural stem cell- and neurogenesis-related gene expression profiles in the young and aged dentate gyrus. Age (Dordr) (2013) 0.83
Caspase-mediated cleavage of C53/LZAP protein causes abnormal microtubule bundling and rupture of the nuclear envelope. Cell Res (2013) 0.78
Single-walled carbon nanohorn (SWNH) aggregates inhibited proliferation of human liver cell lines and promoted apoptosis, especially for hepatoma cell lines. Int J Nanomedicine (2014) 0.77
The RNA-binding profile of Acinus, a peripheral component of the exon junction complex, reveals its role in splicing regulation. RNA (2016) 0.77
Unravelling the proteomic profile of rice meiocytes during early meiosis. Front Plant Sci (2014) 0.77
LZAP is a novel Wip1 binding partner and positive regulator of its phosphatase activity in vitro. Cell Cycle (2016) 0.76
Network Topologies Decoding Cervical Cancer. PLoS One (2015) 0.76
Loss of LZAP inactivates p53 and regulates sensitivity of cells to DNA damage in a p53-dependent manner. Oncogenesis (2017) 0.75
The DNA damage response: putting checkpoints in perspective. Nature (2000) 19.07
Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem (2004) 14.93
Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev (2000) 11.49
Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science (1997) 9.30
Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science (1998) 8.74
Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell (2003) 7.48
Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J Biol Chem (2001) 7.35
ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev (2000) 7.28
The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev (2000) 5.72
Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell (2003) 5.68
Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage. Mol Cell Biol (2005) 4.54
Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. Genes Dev (2000) 4.38
Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nat Cell Biol (2003) 4.31
Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts. Genes Dev (2000) 3.96
cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. Proc Natl Acad Sci U S A (1996) 3.31
Targeting the checkpoint kinases: chemosensitization versus chemoprotection. Nat Rev Cancer (2004) 3.06
Centrosomes in cellular regulation. Annu Rev Cell Dev Biol (2005) 2.89
PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Genes Dev (2005) 2.85
Centrosome control of the cell cycle. Trends Cell Biol (2005) 2.83
Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu Rev Genet (1997) 2.75
Centrosome-associated Chk1 prevents premature activation of cyclin-B-Cdk1 kinase. Nat Cell Biol (2004) 2.63
Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase. Cell Death Differ (2005) 1.98
Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2-M transition. J Cell Sci (2004) 1.93
LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB. Cancer Cell (2007) 1.47
Cloning of three novel neuronal Cdk5 activator binding proteins. Gene (2000) 1.44
Polo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbody. J Biol Chem (2002) 1.44
Activation of caspase-2 in apoptosis. J Biol Chem (1997) 1.35
Depletion of Chk1 leads to premature activation of Cdc2-cyclin B and mitotic catastrophe. J Biol Chem (2005) 1.35
The Wip1 phosphatase (PPM1D) antagonizes activation of the Chk2 tumour suppressor kinase. Oncogene (2006) 1.34
Cdk5 activator-binding protein C53 regulates apoptosis induced by genotoxic stress via modulating the G2/M DNA damage checkpoint. J Biol Chem (2005) 1.24
A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2. Biochem J (2006) 1.14
Checking out the centrosome. Cell Cycle (2004) 1.14
Regulation of Chk2 phosphorylation by interaction with protein phosphatase 2A via its B' regulatory subunit. Biol Cell (2004) 1.12
Regulation of mitotic function of Chk1 through phosphorylation at novel sites by cyclin-dependent kinase 1 (Cdk1). Genes Cells (2006) 1.12
Differential mode of regulation of the checkpoint kinases CHK1 and CHK2 by their regulatory domains. J Biol Chem (2003) 1.09
G1 and S-phase checkpoints, chromosome instability, and cancer. Methods Mol Biol (2004) 0.92
Novel interaction between nuclear co-activator CBP and the CDK5 activator binding protein - C53. Int J Mol Med (2005) 0.81
A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target. Nat Med (2012) 2.39
PDTD: a web-accessible protein database for drug target identification. BMC Bioinformatics (2008) 2.35
PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach. Nucleic Acids Res (2010) 1.50
Structural basis for the regulation of cysteine-protease activity by a new class of protease inhibitors in Plasmodium. Structure (2011) 1.46
Short-term effect of cocoa product consumption on lipid profile: a meta-analysis of randomized controlled trials. Am J Clin Nutr (2010) 1.28
[6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. Cancer Res (2009) 1.26
Cdk5 activator-binding protein C53 regulates apoptosis induced by genotoxic stress via modulating the G2/M DNA damage checkpoint. J Biol Chem (2005) 1.24
A novel C53/LZAP-interacting protein regulates stability of C53/LZAP and DDRGK domain-containing Protein 1 (DDRGK1) and modulates NF-kappaB signaling. J Biol Chem (2010) 1.23
Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors in cancer therapy: advances and perspectives. Curr Pharm Des (2012) 1.11
microRNA-31/factor-inhibiting hypoxia-inducible factor 1 nexus regulates keratinocyte differentiation. Proc Natl Acad Sci U S A (2012) 1.11
Transcriptional regulation of the Ufm1 conjugation system in response to disturbance of the endoplasmic reticulum homeostasis and inhibition of vesicle trafficking. PLoS One (2012) 1.05
Mechanics of channel gating of the nicotinic acetylcholine receptor. PLoS Comput Biol (2008) 1.05
ChemMapper: a versatile web server for exploring pharmacology and chemical structure association based on molecular 3D similarity method. Bioinformatics (2013) 0.99
An improved sequence based prediction protocol for DNA-binding proteins using SVM and comprehensive feature analysis. BMC Bioinformatics (2013) 0.99
MicroRNA-31 targets FIH-1 to positively regulate corneal epithelial glycogen metabolism. FASEB J (2012) 0.99
Mammalian CHORD-containing protein 1 is a novel heat shock protein 90-interacting protein. FEBS Lett (2005) 0.98
Free energy landscape for the binding process of Huperzine A to acetylcholinesterase. Proc Natl Acad Sci U S A (2013) 0.93
eNOS protects prostate cancer cells from TRAIL-induced apoptosis. Cancer Lett (2004) 0.92
Discovery of pteridin-7(8H)-one-based irreversible inhibitors targeting the epidermal growth factor receptor (EGFR) kinase T790M/L858R mutant. J Med Chem (2013) 0.90
SHAFTS: a hybrid approach for 3D molecular similarity calculation. 1. Method and assessment of virtual screening. J Chem Inf Model (2011) 0.89
Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells. Cancer Lett (2006) 0.89
Epstein-Barr virus interactions with the Bcl-2 protein family and apoptosis in human tumor cells. J Zhejiang Univ Sci B (2013) 0.87
Discovery and SAR of thiazolidine-2,4-dione analogues as insulin-like growth factor-1 receptor (IGF-1R) inhibitors via hierarchical virtual screening. J Med Chem (2010) 0.85
Entamoeba histolytica induces intestinal cathelicidins but is resistant to cathelicidin-mediated killing. Infect Immun (2011) 0.85
Investigation of the catalytic mechanism of Sir2 enzyme with QM/MM approach: SN1 vs SN2? J Phys Chem B (2010) 0.85
SHAFTS: a hybrid approach for 3D molecular similarity calculation. 2. Prospective case study in the discovery of diverse p90 ribosomal S6 protein kinase 2 inhibitors to suppress cell migration. J Med Chem (2011) 0.85
Immunoassay for LMP1 in nasopharyngeal tissue based on surface-enhanced Raman scattering. Int J Nanomedicine (2011) 0.84
Apoptosis in the skeletal muscle of untreated children with juvenile dermatomyositis: impact of duration of untreated disease. Clin Immunol (2007) 0.84
Computational methods for drug design and discovery: focus on China. Trends Pharmacol Sci (2013) 0.84
A highly selective space-folded photo-induced electron transfer fluorescent probe for carbonic anhydrase isozymes IX and its applications for biological imaging. Chem Commun (Camb) (2011) 0.84
Design and synthesis of small molecular dual inhibitor of falcipain-2 and dihydrofolate reductase as antimalarial agent. Bioorg Med Chem Lett (2011) 0.84
New aromatic substituted pyrazoles as selective inhibitors of human adipocyte fatty acid-binding protein. Bioorg Med Chem Lett (2011) 0.84
Trefoil factor 3 peptide regulates migration via a Twist-dependent pathway in gastric cell. Biochem Biophys Res Commun (2013) 0.84
Ponatinib efficiently kills imatinib-resistant chronic eosinophilic leukemia cells harboring gatekeeper mutant T674I FIP1L1-PDGFRα: roles of Mcl-1 and β-catenin. Mol Cancer (2014) 0.84
Hypothermia inhibits Fas-mediated apoptosis of primary mouse hepatocytes in culture. Cell Transplant (2004) 0.83
Design and synthesis of small molecule RhoA inhibitors: a new promising therapy for cardiovascular diseases? J Med Chem (2011) 0.83
A new fluorescent chemodosimeter for Hg2+: selectivity, sensitivity, and resistance to Cys and GSH. Org Lett (2010) 0.82
Jacarelhyperol A induced apoptosis in leukaemia cancer cell through inhibition the activity of Bcl-2 proteins. BMC Cancer (2014) 0.82
Discovery of diverse human dihydroorotate dehydrogenase inhibitors as immunosuppressive agents by structure-based virtual screening. J Med Chem (2012) 0.82
microRNA-103/107 Family Regulates Multiple Epithelial Stem Cell Characteristics. Stem Cells (2015) 0.81
Bioactive conformational generation of small molecules: a comparative analysis between force-field and multiple empirical criteria based methods. BMC Bioinformatics (2010) 0.80
Discovering potent inhibitors against the beta-hydroxyacyl-acyl carrier protein dehydratase (FabZ) of Helicobacter pylori: structure-based design, synthesis, bioassay, and crystal structure determination. J Med Chem (2009) 0.80
Fluorescent chemodosimeter for Cys/Hcy with a large absorption shift and imaging in living cells. Org Biomol Chem (2010) 0.80
Discovery of novel selective inhibitors for EGFR-T790M/L858R. Bioorg Med Chem Lett (2011) 0.80
Cyndi: a multi-objective evolution algorithm based method for bioactive molecular conformational generation. BMC Bioinformatics (2009) 0.80
TMEM16A protein attenuates lipopolysaccharide-mediated inflammatory response of human lung epithelial cell line A549. Exp Lung Res (2014) 0.79
A novel, customizable and optimizable parameter method using spherical harmonics for molecular shape similarity comparisons. J Mol Model (2011) 0.79
Anisotropic imprint of amorphization and phase separation in manganite thin films via laser interference irradiation. Small (2014) 0.79
Acenaphtho[1,2-b]pyrrole-based selective fibroblast growth factor receptors 1 (FGFR1) inhibitors: design, synthesis, and biological activity. J Med Chem (2011) 0.79
Quality of life evaluation in juveniles with disorders of sexual development. Pediatr Surg Int (2012) 0.79
An improved PMF scoring function for universally predicting the interactions of a ligand with protein, DNA, and RNA. J Chem Inf Model (2008) 0.79
Structure-activity study on a series of α-glutamic acid scaffold based compounds as new ADAMTS inhibitors. Bioorg Med Chem Lett (2011) 0.78
Pyrimido[4,5-d]pyrimidin-4(1H)-one derivatives as selective inhibitors of EGFR threonine790 to methionine790 (T790M) mutants. Angew Chem Int Ed Engl (2013) 0.78
Natural products as a gold mine for selective matrix metalloproteinases inhibitors. Bioorg Med Chem (2012) 0.78
Imaging of lysosomal pH changes with a fluorescent sensor containing a novel lysosome-locating group. Chem Commun (Camb) (2012) 0.78
Optical Cu2+ probe bearing an 8-hydroxyquinoline subunit: high sensitivity and large fluorescence enhancement. Talanta (2012) 0.78
Novel selective and potent inhibitors of malaria parasite dihydroorotate dehydrogenase: discovery and optimization of dihydrothiophenone derivatives. J Med Chem (2013) 0.78
Design, synthesis, X-ray crystallographic analysis, and biological evaluation of thiazole derivatives as potent and selective inhibitors of human dihydroorotate dehydrogenase. J Med Chem (2015) 0.78
Caspase-mediated cleavage of C53/LZAP protein causes abnormal microtubule bundling and rupture of the nuclear envelope. Cell Res (2013) 0.78
An improved adaptive genetic algorithm for protein-ligand docking. J Comput Aided Mol Des (2008) 0.78
Correlation of Fc(gamma)RIIa (CD32) Polymorphism and IgG Antibody Subclasses in Hemolytic Disease of Newborn. Neonatology (2009) 0.78
[Impact of cytochrome P450 2C19 polymorphisms on outcome of cardiovascular events in clopidogrel-treated Chinese patients after percutaneous coronary intervention]. Zhonghua Xin Xue Guan Bing Za Zhi (2011) 0.77
2-amido-3-(1H-indol-3-yl)-N-substituted-propanamides as a new class of falcipain-2 inhibitors. 1. Design, synthesis, biological evaluation and binding model studies. Molecules (2009) 0.77
FIH-1/c-kit signaling: a novel contributor to corneal epithelial glycogen metabolism. Invest Ophthalmol Vis Sci (2013) 0.77
Synthesis of glucoconjugates of oleanolic acid as inhibitors of glycogen phosphorylase. Carbohydr Res (2009) 0.77
HL005--a new selective PPARγ antagonist specifically inhibits the proliferation of MCF-7. J Steroid Biochem Mol Biol (2011) 0.77
Substituted indolin-2-ones as p90 ribosomal S6 protein kinase 2 (RSK2) inhibitors: Molecular docking simulation and structure-activity relationship analysis. Bioorg Med Chem (2013) 0.77
New thiazole carboxamides as potent inhibitors of Akt kinases. Bioorg Med Chem Lett (2011) 0.76
A simple Calpha-SC potential with higher accuracy for protein fold recognition. Biochem Biophys Res Commun (2009) 0.76
Catalytic asymmetric construction of quaternary α-amino acid containing pyrrolidines through 1,3-dipolar cycloaddition of azomethine ylides to α-aminoacrylates. Chemistry (2013) 0.76
Glucagon-like peptide (GCGL) is a novel potential TSH-releasing factor (TRF) in Chickens: I) Evidence for its potent and specific action on stimulating TSH mRNA expression and secretion in the pituitary. Endocrinology (2014) 0.76
Discovery of new potent inhibitors for carbonic anhydrase IX by structure-based virtual screening. Bioorg Med Chem Lett (2013) 0.76
A generic force field for protein coarse-grained molecular dynamics simulation. Int J Mol Sci (2012) 0.76
Optimizing energy potential for protein fold recognition with parametric evaluation function. J Comput Biol (2009) 0.76
PTID: an integrated web resource and computational tool for agrochemical discovery. Bioinformatics (2012) 0.76
Discovery of natural estrogen receptor modulators with structure-based virtual screening. Bioorg Med Chem Lett (2013) 0.76
Predicting the Drug Safety for Traditional Chinese Medicine through a Comparative Analysis of Withdrawn Drugs Using Pharmacological Network. Evid Based Complement Alternat Med (2013) 0.76
Screening and chromatographic assessing of a novel IgG biomimetic ligand. Biomed Chromatogr (2006) 0.76
Regulation of the Nijmegen breakage syndrome 1 gene NBS1 by c-myc, p53 and coactivators mediates estrogen protection from DNA damage in breast cancer cells. Int J Oncol (2012) 0.76
Benzamide derivatives as dual-action hypoglycemic agents that inhibit glycogen phosphorylase and activate glucokinase. Bioorg Med Chem (2009) 0.76
Discovery of non-peptide inhibitors of Plasmepsin II by structure-based virtual screening. Bioorg Med Chem Lett (2013) 0.75
Optimization of heterocyclic substituted benzenesulfonamides as novel carbonic anhydrase IX inhibitors and their structure activity relationship. Eur J Med Chem (2013) 0.75
Discrimination of colon cancer stem cells using noncanonical amino acid. Chem Commun (Camb) (2012) 0.75
Highly selective and anions controlled fluorescent sensor for Hg(2+) in aqueous environment. J Fluoresc (2008) 0.75
2-(3,4-dihydro-4-oxothieno[2,3-d]pyrimidin-2-ylthio) acetamides as a new class of falcipain-2 inhibitors. 3. design, synthesis and biological evaluation. Molecules (2009) 0.75
Enzymatic preparation and structural determination of oligosaccharides derived from sea cucumber (Acaudina molpadioides) fucoidan. Food Chem (2013) 0.75
Enhanced field emission and photocatalytic performance of MoS₂ titania nanoheterojunctions via two synthetic approaches. Dalton Trans (2015) 0.75
[Treatment of severe displaced proximal humeral fractures with titanium elastic nails in older children]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2014) 0.75
Identification of inhibitors against p90 ribosomal S6 kinase 2 (RSK2) through structure-based virtual screening with the inhibitor-constrained refined homology model. J Chem Inf Model (2011) 0.75
Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1). Eur J Med Chem (2012) 0.75
[Molecular study of two novel RHD alleles and pedigree analysis]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2011) 0.75
A new diaryl urea compound, D181, induces cell cycle arrest in the G1 and M phases by targeting receptor tyrosine kinases and the microtubule skeleton. Invest New Drugs (2010) 0.75
A fluorescence turn-on sensor for Hg2+ with a simple receptor available in sulphide-rich environments. J Fluoresc (2012) 0.75
An IC-PLS framework for group corticomuscular coupling analysis. IEEE Trans Biomed Eng (2013) 0.75
Correction to "Control of the Redox Activity of PbS Quantum Dots by Tuning Electrostatic Interactions at the Quantum Dot/Solvent Interface". J Am Chem Soc (2016) 0.75
Non-covalent Control of the Electrostatic Potential of Quantum Dots through the Formation of Interfacial Ion Pairs. J Am Chem Soc (2017) 0.75
[Sonographic diagnosis of carotid body tumor]. Zhonghua Zhong Liu Za Zhi (2002) 0.75
Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme. Bioorg Med Chem (2007) 0.75
SimG: an alignment based method for evaluating the similarity of small molecules and binding sites. J Chem Inf Model (2013) 0.75